Methods for diagnosing cerebrovascular events based on NR2...

Details Methods for diagnosing cerebrovascular events based on NR2... Methods for diagnosing cerebrovascular events based on NR2...

2006-06-13

2011-12-27

Spector, Lorraine (Department: 1649)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

C435S007210, C530S412000, C702S019000

Reexamination Certificate

active

08084225

ABSTRACT:
Methods and kits for diagnosing and treating cerebrovascular events, and for defining the time and anatomical location of an event, are provided based on the detection and quantification of bound or total and unbound NR2 peptides in biological fluids. The methods are optionally performed in conjunction with neurological scoring and neuroimaging, and are directed to risk assessment, prognosis, diagnosis and treatment of TIA and stroke on an emergency basis in the emergency room.

REFERENCES:
patent: 2003/0096331 (2003-05-01), Dambinova
Dambinova and Skoromets, Stroke, 33: 1181-1182, 2002.
Lai et al. Stroke, 25(5):958-962, May 1994.

Affiliated with

Also associated with

Rating

Methods for diagnosing cerebrovascular events based on NR2... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for diagnosing cerebrovascular events based on NR2..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for diagnosing cerebrovascular events based on NR2... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4301637